Southern Oncology Specialists

Huntersville, North Carolina 28078

1 studies enrolling now · 5 studies all time

What they study most

BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug-Related Side Effects and Adverse Reactions, Multiple Myeloma, Nausea, Neoplasms, Prevention of Chemotherapy-induced Myelosuppression, Vomiting

Studies at this site

• A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer — Recruiting now
• A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat — Completed
• A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer — Stopped early
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed